A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC

Clinical trial NCT03661866 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03661866
Sponsor: Target PharmaSolutions, Inc.
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Atopic Dermatitis Alopecia Areata Hidradenitis Suppurativa Vitiligo Psoriasis Chronic Spontaneous Urticaria

Start date: 2018-12-21
Primary completion: 2050-12-01
Enrollment: 15000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.